Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2021 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's own size, i.e., that what is happening now is disproportionately large relative to the company's smallness. Look for statements about record bookings, growth rates, new logos, etc., but specifically whether they emphasize that the scale of current activity is large relative to the company's size. The transcript shows strong growth, acceleration, record SaaS bookings, etc. But does management explicitly contrast the company's smallness with the scale of what's arriving? They mention "acceleration" and "record" but not necessarily that the company is small relative to the opportunity. They talk about being a leader, but not about being small. They mention "we are thrilled" and "stellar quarter" but no explicit disproportion. They do mention "we are confident we will exit the transition" and "our growth trajectory has never been stronger." However, they don't say "we are small and this is huge relative to us." They do mention "new logos added during the quarter accelerated to over 230" and "subscription ARR growth accelerated to 131%" but that's growth rates, not necessarily disproportion. The question asks: does management convey that the business is outgrowing the company's own size? That would be like "we are a small company and this demand is huge for us." I don't see that. They talk about being a leader, having a strong position, but not about being small relative to the opportunity. They mention "we are well positioned to return to strong profitability" but that's not it. They also mention "we have completed 3/4 of our active subscription transition" and "the number of customers with over $100,000 in ARR is now more than 760 growing faster than 40% year-over-year." That's growth but not disproportion. The key is whether management explicitly or plainly implies that the current activity is large relative to the company's size. They don't say "we are a small company" or "this is huge for us." They talk about acceleration and record results, but that's typical strong quarter language. The answer should be NO because they don't convey that the company is small relative to what's happening. They are a leading player with a large customer base. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.